EU drugs regulator backs Pfizer jab for use in 12-to-15-year-olds
CGTN Europe
•
2m 14s
The European Medicines Agency (EMA) has approved the Pfizer-BioNTech COVID-19 vaccine for use in children aged 12 to 15, likely pushing back the date by which Europe will have surplus jabs to share with the developing world.
The EMA's human medicines committee said a trial in 2,260 children found the vaccine was safe for use, with no unusual side effects.
"Extending the protection of a safe and effective vaccine in this younger population is an important step forward in the fight against the pandemic," Marco Cavaleri, the EMA's head of biological health threats and vaccines strategy, told reporters.
📲 Follow CGTN Europe on social media and other platforms👇🏼
https://stories.cgtneurope.tv/follow-cgtn-europe/index.html
Up Next in CGTN Europe
-
German scientists may have answer to ...
In the COVID-19 vaccine world, AstraZeneca and Johnson & Johnson have been given a bad rep over fears that they might cause blood-clots.
Because of that, Austria, Denmark and Norway have dropped the viral vector vaccines from their vaccination campaigns.
But now, a team of scientists in ...
-
Quick Take: Ten stories you may have ...
📱 Huawei confirmed it will launch its new software next week, 🌞 the Belt and Road initiative donates solar panels to Cuba, 🌾 China’s agronomist Yuan Longping died aged 91...
Here are ten stories you may have missed in #China this week.
📲 Follow CGTN Europe on social media and other platforms👇🏼
... -
The gender gap grows - #TheAgenda wit...
The World Economic Forum has been publishing an annual Gender Gap Report for the past 15 years.
It examines the divide between men and women across the globe in four major areas – economics, education, healthcare and politics.
And while the gaps are closing in some of those areas, in others –...
